Seres Therapeutics, Inc. (MCRB)
15.57
+0.38
(+2.50%)
USD |
NASDAQ |
Jan 06, 16:00
15.57
0.00 (0.00%)
After-Hours: 16:30
Seres Therapeutics Total Assets (Quarterly): 143.47M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 218.45M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
| Oragenics, Inc. | 12.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 99.78M |
| Shareholders Equity (Quarterly) | 43.70M |
| Debt to Equity Ratio | 1.951 |
| Current Ratio | 2.297 |
| Net Debt Paydown Yield | 15.12% |